SEA Stories

Prostate Cancer Support Group Meeting & Webcast on Chemotherapy

Sponsored by: Sanofi Genzym
Hosted by the Us TOO Palatine/Inverness Support Group.

This discussion on chemotherapy for prostate cancer treatment provides accurate, objective, educational content to address:

  • What is chemotherapy and how does it work
  • Current/updated chemotherapy treatment paradigm; how has it changed and why
  • How does chemotherapy fit into the sequencing of therapies
  • When is chemotherapy combined with other therapies
  • Impact of chemotherapy for patients with the AR-V7 biomarker (indicating a resistant to hormone therapy)

Hosted by Cliff Whall, Leader of the Us TOO support group in Palatine/Inverness, IL, and featuring physician presenter Daniel H. Shevrin, M.D., a medical oncologist in Evanston, IL with more than 20 years of experience. He is affiliated with multiple hospitals in the area, including NorthShore Skokie Hospital and NorthShore University Health-Evanston Hospital.

View the full video by clicking on the image below; or scroll down to access links to short video segments about specific content presented at the event.

Click any link listed below to go straight to that segment of the video:

  • 0:01 - Intro, About Us TOO - Chuck Strand, CEO, Us TOO International
  • 4:59 - Cliff Whall, Us TOO Inverness Support Group Leader
  • 12:58 - Intro to Dr. Daniel H. Shevrin - Medical Oncologist, NorthShore University HealthSystem
  • 13:26 - Dr. Shevrin
  • 15:45 - Chemotherapy History
  • 16:56 - Chemotherapy - How Does it Work?
  • 22:53 - Side Effects of Chemotherapy
  • 26:47 - Management of Side Effects
  • 29:52 - Drugs - Taxotere (Docetaxel)
  • 35:12 - Drugs - Jeutana (Cabazitaxel)
  • 38:38 - When Do We Use Chemotherapy?/Guidelines
  • 42:26 - CHAARTED Trial
  • 46:19 - Stampede Trial
  • 49:07 - AR-V7 Biomarker
  • 52:45 - Chemotherapy for Very Aggressive Prostate Cancer
  • 54:03 - Sequencing
  • 57:27 - Chemotherapy Myths
  • 1:01:01 - Q&A

CLICK HERE and opt-in to receive free educational emails from Us TOO.